|
WO2020177728A1
|
|
Fatty acid composition and application thereof
|
|
CN108530360A
|
|
A kind of higher celecoxib pharmaceutical composition of safety
|
|
CN109200061A
|
|
A kind of blood-fat reducing composition of high-purity fish oil and phytosterin ester
|
|
CN105434393A
|
|
Soft capsule containing high-content omega-3 polyunsaturated fatty acid
|
|
CN105218367A
|
|
A kind of High Purity Ethyl Eicosapentaenoate enriched material
|
|
CN104414978A
|
|
Enteric-coated micropellet containing esomeprazole magnesium
|
|
CN103343048A
|
|
Method for reducing anisidine value of high-content fish oil
|
|
CN104250243A
|
|
Preparation method of esomeprazole magnesium dihydrate A crystal form
|
|
CN103989657A
|
|
Celecoxib-containing capsule
|
|
CN102952131A
|
|
Preparation method of moxifloxacin hydrochloride
|
